Search Browse Earnings

Caribou Biosciences, Inc.

Nasdaq:CRBU

Biological Products, (No Diagnostic Substances)·BERKELEY, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Caribou Biosciences, Inc. — SlamSEC

Revenue

$10.0M

-71.0% YoY

FY 2025

Adj. EBITDA

-$162.7M

-1627.9% margin

FY 2025

Net Income

-$149.1M

-1491.9% margin

FY 2025

EPS (Diluted)

-$1.65

FY 2025

Stock Price

$1.81

+6.1%

2026-03-06

52W Range

$0.66 – $3.54

P/E Ratio

-1.1x

Market Cap

$175.4M

Cash

$16.3M

FY 2025

Total Debt

—

Net Cash

$16.3M

FY 2025

Enterprise Value

$159.1M

Debt / EBITDA

0.1x

FY 2025

EV / EBITDA

-1.0x

Employees

—